MAP3K8 and hepatocellular carcinoma: To further explore the underlying role of MAP3K8 in HCC, we analyzed the Timer database and identified the expression of MAP3K8 in tumor tissues was higher than that in normal tissues; this was further verified by immunohistochemistry and RT-qPCR (Fig. 5a,5b,5c).